Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcus Biosciences (RCUS) Tax Provisions (2021 - 2024)

Arcus Biosciences (RCUS) has 3 years of Tax Provisions data on record, last reported at $1.0 million in Q4 2023.

  • For Q4 2023, Tax Provisions rose 25100.0% year-over-year to $1.0 million; the TTM value through Sep 2024 reached $1.0 million, down 79.98%, while the annual FY2024 figure was $1.0 million, 83.33% down from the prior year.
  • Tax Provisions reached $1.0 million in Q4 2023 per RCUS's latest filing, down from $2.0 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $2.0 million in Q4 2021 and bottomed at -$4000.0 in Q4 2022.
  • Average Tax Provisions over 3 years is $1.3 million, with a median of $1.0 million recorded in 2022.
  • Peak YoY movement for Tax Provisions: crashed 100.2% in 2022, then skyrocketed 25100.0% in 2023.
  • A 3-year view of Tax Provisions shows it stood at $2.0 million in 2021, then plummeted by 100.2% to -$4000.0 in 2022, then surged by 25100.0% to $1.0 million in 2023.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $1.0 million in Q4 2023, $2.0 million in Q3 2023, and $1.0 million in Q2 2023.